Nissenson, Allen R.
Data and Safety Monitoring Board,
United States
2025 Rank: 19092
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
General & Internal Medicine
Rank in SubField 1: 206 out of 92052 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 19092 | 20563 |
| Total Cites | 28212 | 30948 |
| H-index | 67 | 72 |
| Hm-index | 27 | 27 |
| Number of Single Authored Papers | 59 | 59 |
| Total Cites to Single Authored Papers | 624 | 652 |
| Number of Single+First Authored Papers | 138 | 138 |
| Total Cites to Single+First Authored Papers | 2478 | 2666 |
| Number of Single+First+Last Authored Papers | 235 | 235 |
| Total Cites to Single+First+Last Authored Papers | 5240 | 5652 |
| Composite Score | 3 | 4 |
| Number of Distinct Citing Papers | 24566 | 26138 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.18 |
| Self-Citation Percentage |
8.84%
|
|
Nissenson, Allen R.
David Geffen School of Medicine at UCLA,
United States
2024 Rank: 18078
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
General & Internal Medicine
Rank in SubField 1: 196 out of 87532 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 18078 | 18903 |
| Total Cites | 27245 | 29968 |
| H-index | 65 | 70 |
| Hm-index | 26 | 27 |
| Number of Single Authored Papers | 59 | 59 |
| Total Cites to Single Authored Papers | 619 | 647 |
| Number of Single+First Authored Papers | 137 | 137 |
| Total Cites to Single+First Authored Papers | 2429 | 2617 |
| Number of Single+First+Last Authored Papers | 234 | 234 |
| Total Cites to Single+First+Last Authored Papers | 5090 | 5515 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 23701 | 25262 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.19 |
| Self-Citation Percentage |
9.09%
|
|
Nissenson, Allen R.
DaVita Inc.,
United States
2023 Rank: 17482
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
General & Internal Medicine
Rank in SubField 1: 190 out of 82885 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 17482 | 18120 |
| Total Cites | 25763 | 28219 |
| H-index | 62 | 67 |
| Hm-index | 25 | 27 |
| Number of Single Authored Papers | 58 | 58 |
| Total Cites to Single Authored Papers | 608 | 634 |
| Number of Single+First Authored Papers | 134 | 134 |
| Total Cites to Single+First Authored Papers | 2382 | 2566 |
| Number of Single+First+Last Authored Papers | 231 | 231 |
| Total Cites to Single+First+Last Authored Papers | 4940 | 5359 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 22465 | 23853 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.18 |
| Self-Citation Percentage |
8.70%
|
|
Nissenson, Allen R.
David Geffen School of Medicine at UCLA,
United States
2022 Rank: 15993
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
General & Internal Medicine
Rank in SubField 1: 171 out of 79729 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 15993 | 16954 |
| Total Cites | 24903 | 27501 |
| H-index | 61 | 65 |
| Hm-index | 25 | 27 |
| Number of Single Authored Papers | 58 | 58 |
| Total Cites to Single Authored Papers | 594 | 620 |
| Number of Single+First Authored Papers | 131 | 131 |
| Total Cites to Single+First Authored Papers | 2309 | 2493 |
| Number of Single+First+Last Authored Papers | 225 | 225 |
| Total Cites to Single+First+Last Authored Papers | 4701 | 5113 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 21611 | 23096 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.19 |
| Self-Citation Percentage |
9.45%
|
|
Nissenson, Allen R.
DaVita Inc.,
United States
2021 Rank: 16677
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
General & Internal Medicine
Rank in SubField 1: 176 out of 76322 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 16677 | 17161 |
| Total Cites | 23328 | 25818 |
| H-index | 59 | 64 |
| Hm-index | 24 | 26 |
| Number of Single Authored Papers | 58 | 58 |
| Total Cites to Single Authored Papers | 573 | 596 |
| Number of Single+First Authored Papers | 131 | 131 |
| Total Cites to Single+First Authored Papers | 2215 | 2388 |
| Number of Single+First+Last Authored Papers | 225 | 225 |
| Total Cites to Single+First+Last Authored Papers | 4497 | 4885 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 20254 | 21682 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.19 |
| Self-Citation Percentage |
9.64%
|
|
Nissenson, Allen R.
DaVita Inc.,
United States
2020 Rank: 14986
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
General & Internal Medicine
Rank in SubField 1: 165 out of 64516 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 14986 | 16004 |
| Total Cites | 21991 | 24412 |
| H-index | 56 | 61 |
| Hm-index | 24 | 25 |
| Number of Single Authored Papers | 59 | 59 |
| Total Cites to Single Authored Papers | 577 | 600 |
| Number of Single+First Authored Papers | 132 | 132 |
| Total Cites to Single+First Authored Papers | 2159 | 2331 |
| Number of Single+First+Last Authored Papers | 227 | 227 |
| Total Cites to Single+First+Last Authored Papers | 4293 | 4676 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 19047 | 20434 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.19 |
| Self-Citation Percentage |
9.92%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.